To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...

~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

GD2 CAR-modified T cells have induced complete responses in some children with neuroblastoma. Clinical trials with EGFRvIII CARs and IL-13 zetakine are underway for adults with brain tumors ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different ...

Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...

clinical nurse specialists, and independent hospice and home care nurses are often the first members of the health care team to see the patient and detect the signs and symptoms of SCC.